Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Bracing for a Mold-filled Fall: How to Treat your Mold Allergy
  • USA - English


News provided by

Allergychoices

Sep 25, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Onalaska, WI (PRWEB) September 25, 2017 -- As pollen season comes to a close, many allergy sufferers continue to experience allergy symptoms, likely due to mold. Because mold tends to grow any place that is damp, dark and warm, it’s very common during the fall months. Considering the rains and flooding around the country, symptoms from mold allergy are expected to be even more prevalent than usual. Helping people learn to build short-term allergy relief and long-term tolerance has been a focus of treatment through the La Crosse Method™ Practice Protocol, which uses allergy drops rather than allergy shots to treat mold allergy and more.

With so many different molds in our environment, it’s difficult to identify which one(s) could be causing allergy symptoms. Mike Kachel, RPh, Allergychoices Pharmacy Director, explains that this fall, alternaria is going to be a mold that causes suffering for many. Though it’s around from spring to fall, with the typical fall weather conditions, it’s known to prevail beyond that time.

Kachel explains that alternaria is common inside as well as outside, making it nearly impossible to avoid. While alternaria is the most common mold, and the most common mold to cause allergy symptoms, other molds can cause reactions, too. “There are the big five: Alternaria, cladosporium, aspergillus, penicillum, and helminthosporium. They’re the most prevalent, but there are hundreds of different molds. Just because a patient’s allergy test doesn’t show sensitivity to one of the common molds doesn’t mean another mold couldn’t be triggering allergy symptoms.” Allergychoices has created a reference that helps people identify the different types of molds and when they’re most commonly found.

The prevalence of mold is an issue for many due to its allergic tendencies. Symptoms can range from aggravated asthma conditions to eye itching, sneezing, sinus pressure, aching, exhaustion or throat drainage. Because people are often allergic to more than one mold, a patient might experience one set of symptoms one day and different symptoms the next, making it often difficult to diagnose. Because of the long mold season, and because of the inflammation the mold can cause in the sinuses, one of the common allergic complications is chronic sinus infections.

While there are a few treatment options, sublingual immunotherapy (SLIT), also known as allergy drops, has been shown to be a safe and effective way to address the root cause of mold allergy. Like allergy shots, allergy drops work by gradually building the body’s tolerance to the substances causing allergic reactions, but allergens are placed in liquid form under the tongue where the body’s largest amount of tolerance-building cells are located. Allergychoices’ pharmacy compounds prescriptions under the La Crosse Method Protocol for inhalants, foods, and offending molds at very precise levels that are custom to each patient’s sensitivity, at a dose that prescribers match to the patient’s individual allergic “fingerprint.”

Along with treatment, these lifestyle measures are recommended to help combat mold and reduce exposure:
• Close your windows and turn on air conditioning if humidity is an issue; relative humidity should be around 40-45%.
• After spending time outdoors, shower, change clothes and use saline irrigation in your nose.

If you find mold in your home, first identify the source to stop any additional problems:
• Isolate the area by closing it off
• Remove any wet or mold-damaged materials, or work with professionals to do so, and place in plastic bags (many experts recommend at least 6 mil thick bags, and to double bag)
• Clean the affected area with one part bleach and three parts water
• Use fans and/or dehumidifiers to dry
• Don’t wait! Clean up should be immediate. Be sure to wear personal protection (goggles, N95 respirator, gloves, etc.), or consider bringing in mold remediation experts for larger jobs. Find out more about mold remediation at https://www.epa.gov/mold.

For more information about mold allergy treatment, visit https://www.allergychoices.com/about-allergy-drops/conditions-best-treated-with-allergy-drops/mold-allergy/ or call 866-793-1680.

About Allergychoices, Inc.
Allergychoices began in 2000 as the first dedicated education, advocacy, and networking resource for patients and physicians who were interested in sublingual immunotherapy to treat the underlying cause of allergic disease in the U.S. It was founded by allergy providers who developed the La Crosse Method Protocol, based on decades of clinical experience at their Allergy Associates of La Crosse practice in Wisconsin. Today, the company has grown to be a leading healthcare services company that provides tools that enable physicians across the U.S. to provide sublingual immunotherapy within patients’ reach, and gives allergy sufferers information and access to treatment options using custom sublingual immunotherapy close to home.

Anne Hendrickson, Allergychoices, http://www.allergychoices.com, +1 608-791-5300, [email protected]

Modal title

There has been little to offer patients suffering from mold and food allergies. Clinical evidence shows a great deal of promise in treating food and mold allergies through sublingual immunotherapy.
There has been little to offer patients suffering from mold and food allergies. Clinical evidence shows a great deal of promise in treating food and mold allergies through sublingual immunotherapy.
Mold allergy identification
View PDF
Mold allergy identification
There has been little to offer patients suffering from mold and food allergies. Clinical evidence shows a great deal of promise in treating food and mold allergies through sublingual immunotherapy. Mold allergy identification

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.